These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27182162)

  • 1. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.
    Wang HJ; Jiang YF; Wang XR; Zhang ML; Gao PJ
    World J Gastroenterol; 2016 May; 22(18):4529-37. PubMed ID: 27182162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic changes of Th1/Th2 type cytokines in peripheral blood of patients with hepatitis B e antigen-positive chronic hepatitis B treated with telbivudine].
    Zhang L; Zhang DZ; Chen M; He H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):175-9. PubMed ID: 19335978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.
    Zhang Y; Lian JQ; Li Y; Wang JP; Huang CX; Bai XF; Wang JP
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):814-9. PubMed ID: 23406845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ; Hu JJ; Xue JY; Yin W; Liu YY; Fan WH; Xu H; Liang XS
    World J Gastroenterol; 2014 Jul; 20(28):9486-96. PubMed ID: 25071343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.
    Piccolo P; Lenci I; di Paolo D; Demelia L; Sorbello O; Nosotti L; Angelico M
    Antivir Ther; 2013; 18(1):57-64. PubMed ID: 22872648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
    Li Y; Zhang Y; Wang JP; Lian JQ; Bai XF
    J Viral Hepat; 2013 Apr; 20 Suppl 1():46-51. PubMed ID: 23458524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X; Li J; Liu J; Gao M; Zhou L; Lu W
    Medicine (Baltimore); 2017 Jun; 96(23):e7064. PubMed ID: 28591041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.
    Wang CC; Lin CL; Hsieh TY; Tseng KC; Peng CY; Su TH; Yang SS; Hsu YC; Chen TM; Kao JH
    Hepatol Int; 2016 Mar; 10(2):294-301. PubMed ID: 26399763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
    Ma SW; Huang X; Li YY; Tang LB; Sun XF; Jiang XT; Zhang YX; Sun J; Liu ZH; Abbott WG; Dong YH; Naoumov NV; Hou JL
    J Hepatol; 2012 Apr; 56(4):775-81. PubMed ID: 22173154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients].
    Zhang W; Sandeep KK; Zhang QF; Guo SH; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):570-4. PubMed ID: 24119734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    Liu X; Shen Z; Zhang H; Liang J; Lin H
    J Interferon Cytokine Res; 2016 Jun; 36(6):367-73. PubMed ID: 26840345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
    Lv GC; Ma WJ; Ying LJ; Jin X; Zheng L; Yang YD
    World J Gastroenterol; 2010 Aug; 16(32):4095-9. PubMed ID: 20731026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum interleukin-26 level is a potential biomarker for chronical hepatitis B.
    Luo L; Jiang L; Tian Z; Zhang X
    Medicine (Baltimore); 2020 Jan; 99(1):e18462. PubMed ID: 31895778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Th17 cytokines during telbivudine therapy in patients with chronic hepatitis B.
    Hao C; Wang J; Kang W; Xie Y; Zhou Y; Ma L; Peng M; Bai X; Lian J; Jia Z
    Viral Immunol; 2013 Oct; 26(5):336-42. PubMed ID: 24028690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.